Ameriprise’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-81,688
| Closed | -$1.28M | – | 3968 |
|
|
2024
Q1 | $1.28M | Buy |
81,688
+3,523
| +5% | +$54.2K | ﹤0.01% | 3069 |
|
|
2023
Q4 | $1.26M | Sell |
78,165
-48,644
| -38% | -$621K | ﹤0.01% | 3096 |
|
|
2023
Q3 | $1.61M | Sell |
126,809
-13,561
| -10% | -$187K | ﹤0.01% | 2929 |
|
|
2023
Q2 | $1.98M | Buy |
140,370
+25,520
| +22% | +$365K | ﹤0.01% | 2881 |
|
|
2023
Q1 | $1.77M | Sell |
114,850
-5,742
| -5% | -$95.9K | ﹤0.01% | 2898 |
|
|
2022
Q4 | $1.98M | Sell |
120,592
-23,244
| -16% | -$378K | ﹤0.01% | 2817 |
|
|
2022
Q3 | $2.66M | Buy |
143,836
+70,269
| +96% | +$1.1M | ﹤0.01% | 2648 |
|
|
2022
Q2 | $967K | Buy |
+73,567
| New | +$812K | ﹤0.01% | 3138 |
|
|
2021
Q2 | – | Sell |
-8,921
| Closed | -$400K | – | 3982 |
|
|
2021
Q1 | $400K | Sell |
8,921
-35,841
| -80% | -$1.67M | ﹤0.01% | 3484 |
|
|
2020
Q4 | $2.56M | Buy |
44,762
+19,761
| +79% | +$1.17M | ﹤0.01% | 2671 |
|
|
2020
Q3 | $1.28M | Sell |
25,001
-30
| -0.1% | -$1.47K | ﹤0.01% | 2869 |
|
|
2020
Q2 | $1.5M | Buy |
+25,031
| New | +$1.34M | ﹤0.01% | 2744 |
|
|
2020
Q1 | – | Sell |
-4,505
| Closed | -$280K | – | 3759 |
|
|
2019
Q4 | $280K | Buy |
+4,505
| New | +$214K | ﹤0.01% | 3499 |
|
|
2018
Q4 | – | Sell |
-24,807
| Closed | -$961K | – | 3785 |
|
|
2018
Q3 | $961K | Sell |
24,807
-4,259
| -15% | -$157K | ﹤0.01% | 3095 |
|
|
2018
Q2 | $1.14M | Buy |
+29,066
| New | +$856K | ﹤0.01% | 2965 |
|
Other funds holding DCPH
Ameriprise's DCPH Position: Q2 2024 in Review
Ameriprise sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 81,688 shares — an estimated $1.28M sold.
Ameriprise first reported a position in DCPH in Q2 2018 and held it in 15 quarters. The position peaked at $2.66M in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Ameriprise reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Ameriprise sold 81,688 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.28M.
- Ameriprise first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 15 quarters.
- Ameriprise's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.66M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.